Clamp for Safety: Improving Intravesical Chemotherapy Practices

Author:

Robison Michelle,Bush Nancy Jo

Abstract

ABSTRACTProcesses for intravesical chemotherapy after transurethral resection of nonmuscle invasive bladder tumors may lack standardization. In 2019, at a large health care system in Los Angeles, California, five incident reports involving chemotherapeutic agent spills from urinary catheters after bladder tumor procedures necessitated a quality improvement project. The project lead determined that a cost‐effective alternative device for securing the chemotherapeutic agent in the bladder was needed at four surgical locations of the health care system. In addition, a review of the literature and an observational assessment revealed lack of adherence to standard and recommended processes for using personal protective equipment (PPE) when handling hazardous medications. After revising existing processes, acquiring a cost‐effective clamp and recommended chemotherapy PPE, instructing personnel on the clamping process and use of PPE, and implementing use of the clamp, there have been no spills associated with intravesical chemotherapy across the four surgical locations.

Publisher

Wiley

Reference21 articles.

1. Cancer Statistics, 2021

2. Key statistics for bladder cancer.American Cancer Society. Revised January 19 2024. Accessed January 25 2024.https://www.cancer.org/cancer/types/bladder‐cancer/about/key‐statistics

3. American Urological Association Society of Urologic Nurses and Associates.Intravesical Administration of Therapeutic Medication for the Treatment of Bladder Cancer. Amended September2020. Accessed January 18 2024.https://www.auanet.org/about‐us/policy‐and‐position‐statements/intravesical‐administration‐of‐therapeutic‐medication

4. European Association of Urology Guidelines on Non–muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3